CDK2 and acute myeloid leukemia: The molecule induced cell cycle arrest in the G0/G1 phase and apoptosis in a concentration-dependent manner and inhibited phosphorylation of the downstream CDK2/4 factor RB and of FLT3 in the MV4-11 AML cell line.